Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Percheron Therapeutics (AU:PER)
ASX:PER
RESEARCH TOOLSreports
Holding AU:PER?
Track your performance easily
See the Price Targets and Ratings of:
PER Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PER Stock 12 Month Forecast
Average Price Target
AU$0.26
▲(226.36% Upside)
| Highest Price TargetAU$0.27 | Average Price TargetAU$0.26 | Lowest Price TargetAU$0.24 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wilsons
Reiterated
10/08/24
Morgans
Reiterated
09/02/24
Best Analysts Covering Percheron Therapeutics
Which Analyst Should I Follow If I Want to Buy AU:PER and Sell After:
1 Month
xxx
Success Rate
3/6 ratings generated profit
Average Return
-0.12%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -0.12% per trade.
3 Months
xxx
Success Rate
3/6 ratings generated profit
Average Return
+2.98%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +2.98% per trade.
1 Year
Success Rate
0/6 ratings generated profit
Average Return
-42.15%
reiterated a buy rating 2 months ago
Copying Iain Wilkie's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -42.15% per trade.
2 Years
xxx
Success Rate
0/6 ratings generated profit
Average Return
-64.77%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -64.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PER Analyst Recommendation Trends
Rating
Jan 24
Apr 24
May 24
Sep 24
Oct 24
Strong Buy
3
3
3
3
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
PER Financial Forecast
PER Stock Forecast FAQ
What is AU:PER’s average 12-month price target, according to analysts?
Based on analyst ratings, Percheron Therapeutics’s 12-month average price target is AU$0.26.
What is AU:PER’s upside potential, based on the analysts’ average price target?
Percheron Therapeutics has 226.36% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Percheron Therapeutics a Buy, Sell or Hold?
Percheron Therapeutics has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Percheron Therapeutics’s share price target?
The average share price target for Percheron Therapeutics is AU$0.26. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$0.27 ,and the lowest forecast is AU$0.24. The average share price target represents 226.36% Increase from the current price of <AU$0.1.
The highest analyst share price target is AU$0.27 ,and the lowest forecast is AU$0.24. The average share price target represents 226.36% Increase from the current price of <AU$0.1.
What do analysts say about Percheron Therapeutics?
Percheron Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Percheron Therapeutics?
To buy shares of AU:PER, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.